Small company, big ambitions.
What a mission
Inspira Pharmaceuticals Limited is a UK based company conducting research and development on its IPA formulations which have potential therapeutic applications for respiratory diseases. Our mission is to develop our technology into approved medicines for the treatment of several target diseases, including COVID-19.
We are moving fast so enter your email address below to stay informed about our news.
"IPA-001 displayed viricidal activity against SARS-CoV2 after 5 minutes contact time"
Virology Research Services, London
Changing the Game
With our platform technology, we are striving to improve global health outcomes. Founded in 2020 but leveraging on over a decade of research, our team of scientists, entrepreneurs and advisers have worked tirelessly to position Inspira as a new force in respiratory disease innovation. Are you an energised pioneer in your field? Maybe you would be a perfect fit to join us.
What We Are Doing
Partnering with the best
At Inspira Pharmaceuticals Limited, we have teamed up with some of the best minds in virology, respiratory disease and inhaled drug therapies. We’ve only just begun, but we already know that we've got a real chance to be part of the solution for a global problem. In 2021 we will be working with our partners to complete an aggressive drug development program on our leading IPA formulations to test the efficacy of our technology for the treatment of COVID-19.